ChemImage's 106th patent acknowledges Raman Molecular Imaging (RMI) as a way to assess similar-looking tissue samples in the diagnosing of renal disease tissue.
Scientists at ChemImage Corporation are one step closer to making objective diagnoses of renal disease tissue a reality today with the issuance of pat ...
Satisfied Users & 
Approved Press Releases
